信达证券给予美好医疗买入评级：短期承压，新业务起量，长期成长可期

Group 1 - The core viewpoint of the report is that Cinda Securities has given a "buy" rating for Meihua Medical (301363.SZ) with a latest price of 23.4 yuan [2] - The first reason for the rating is that the cornerstone business is under pressure due to tariff disturbances, but the new business expansion has shown significant results [2] - The second reason is that increased investment is expected to enhance profitability in the long term [2]